Benchmark Capital Advisors »

Trinity Biotech shares owned by Benchmark Capital Advisors

Quarter-by-quarter ownership of Trinity Biotech shares owned by Benchmark Capital Advisors from 13F filings

Historical chart of Benchmark Capital Advisors investment in Trinity Biotech

Tip: Access up to 7 years of quarterly data

All positions including Trinity Biotech held by Benchmark Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trinity Biotech by Benchmark Capital Advisors

Quarter filed Position value Share count Share price at filing
2018-12-31 $39k 17k 2.29
2018-09-30 $79k 20k 4.00
2018-06-30 $99k 20k 5.02
2018-03-31 $118k 23k 5.15
2017-12-31 $122k 24k 5.09
2017-09-30 $213k 38k 5.62
2017-06-30 $241k 40k 6.00
2017-03-31 $241k 41k 5.95
2016-12-31 $329k 48k 6.92
2016-09-30 $1.3M 97k 13.22
2016-06-30 $1.0M 91k 11.34
2016-03-31 $974k 84k 11.66
2015-12-31 $1.0M 89k 11.76
2015-09-30 $1.0M 90k 11.44
2015-06-30 $1.7M 92k 18.05
2015-03-31 $1.8M 92k 19.24
2014-12-31 $1.3M 72k 17.51
2014-09-30 $1.3M 71k 18.27
2014-06-30 $1.3M 57k 23.04
2014-03-31 $1.4M 57k 24.23
2013-12-31 $1.4M 57k 25.14
2013-09-30 $1.2M 57k 21.75
2013-06-30 $869k 52k 16.84
2013-03-31 $363k 22k 16.88
2012-12-31 $288k 20k 14.40
2012-09-30 $207k 17k 12.55